Alterations in the rap1 signaling pathway are common in human gliomas

Oncogene

Volumn 15, Issue 13, 1997, Pages 1611-1616

  Gutmann, David H ^a   Saporito Irwin, Susan ^a   DeClue, Jeffrey E ^b   Wienecke, Ralf ^b   Guha, Abhijit ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Astrocytomas; Tuberin; Tuberous sclerosis complex 2; Tumor suppressor gene

Indexed keywords

REGULATOR PROTEIN; TUBERIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMOMA; GLIOMA; HUMAN; HUMAN TISSUE; MENINGIOMA; NERVOUS SYSTEM TUMOR; NEURILEMOMA; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 0030680228     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201314     Document Type: Article

References (22)

1. Cheng Y-T, Li Y-L, Wu JD, Long S-B, Tzai T-S, Tzeng C-C and Lai M-D. (1995). Mol. Carinogen., 13, 173-181.
2. Geist RT, Reddy AJ, Zhang J and Gutmann DH. (1996). Neurobiol. Dis., 3, 111-120.
3. Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D and Guha A. (1996). Oncogene, 12, 2121-2127.
4. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS and James CD. (1994). Cancer Res., 54, 5804-5807.
5. He J, Olson JJ and James CD. (1995). Cancer Res., 55, 4833-4836.
6. Hewett SJ, Choi DW, and Gutmann DH. (1995). Neuroreport. 6, 1505-1508.
7. Jin F, Wienecke R, Xiao G-H, Maize JC, DeClue JE and Yeung RS. (1996). Proc. Natl. Acad. Sci. USA, 93, 9154-9159.
8. Johnson MR, Look AT, DeClue JE, Valentine MB and Lowy DR. (1993). Proc. Natl. Acad. Sci. USA, 90, 5539-5543.
9. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look TA. (1993). Cancer Res., 53, 5535-5541.
10. Kraus J, Koopman J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler DD and von Deimling A. (1996). J. Neuropath. Exper. Neurol., 54, 91-95.
11. Louis DN and Gusella JF. (1995). Trends in Genet., 11, 111-114.
12. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, and Takai Y. (1996). J. Biol. Chem., 271, 1258-1261.
13. Olson JJ, James CD, Krisht A, Barnett D and Hunter S. (1995). Neurosurgery, 36, 740-748.
14. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP. (1994). Amer. J. Pathol., 145, 1175-1190.
15. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS and Collins VP. (1996). Cancer Res., 56, 5141-5145.
16. Roy NV, Forus A, Myklebost O, Cheng NC, Versteeg R and Speleman F. (1995). Cancer Genet. Cytogenet., 82, 151-154.
17. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF and Bernards A. (1993). Nature Genetics, 3, 62-66.
18. Wienecke R, Konig A and DeClue JE. (1995). J. Biol. Chem., 270, 16409-16414.
19. Wienecke R, Maize Jr JC, Reed J, de Gunzburg J, Yeung RS and DeClue JE. (1996). Oncogene, 13, 913-923.
20. Wienecke R, Maize Jr JC, Reed J, de Gunzburg J, Yeung RS and DeClue JE. (1997). Am. J. Pathol., 150, 43-50.
21. Wienecke R, Guha A, Maize JC, Heideman RL, DeClue JE and Gutmann DH. (1997). Annals of Neurology, (in press).
22. Yoshida Y, Kawata M, Miura Y, Musha T, Sasaki T, Kikuchi A and Takai Y. (1992). Mol. Cell. Biol., 12, 3407-3414.